title: A study of erythropoiesis and iron metabolism in the rabbit in vivo. II. Dependence of the response on iron storage and transport.
abstract: Rabbits subjected to a daily bloodletting schedule of 10 ml blood per kg body weight increase four- or fivefold their erythropoietic production compared to normal non-bled animals. The maximum response they can reach under these conditions mobilizes more than 9 mg of iron per day per rabbit into hemoglobin. When fed ad libitum with their regular diet, they do not need any further iron supplement for full erythropoiesis. The experimental increment in iron body stores and/or serum iron levels does not enhance their erythropoietic response, demonstrating that iron is not rate limiting under the conditions studied. Furthermore, although serum iron levels are elevated onefold in the controls under chronic anemia with respect to non-bled animals, the concentration of serum transferrin is only slightly increased; hence, the iron saturation of this protein changes from a 50% to an 80% level. In the absence of an extra supplement of iron, rabbits subjected to chronic bloodletting show no signs of body iron depletion, as judged by their continuous macrocytic RBC production.
authors.affiliation: Departamento de Biología, Facultad de Ciencias, Universidad Nacional Autónoma de México, D.F.
authors.forename: L A
authors.initials: LA
authors.lastname: Lois
authors.forename: A
authors.initials: A
authors.lastname: Mainero
authors.forename: V M
authors.initials: VM
authors.lastname: Váldes-López
authors.forename: L
authors.initials: L
authors.lastname: Benavides
authors.forename: J
authors.initials: J
authors.lastname: Martínez-Medellín
mesh_terms: D000740:Anemia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D000818:Animals; D001692:Biological Transport; D001815:Bloodletting / Q000009:adverse effects; D004909:Erythrocyte Indices / Q000187:drug effects; D004920:Erythropoiesis; D005260:Female; D006454:Hemoglobins / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007501:Iron / Q000378:metabolism*; D007505:Iron-Dextran Complex / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D011817:Rabbits / Q000378:metabolism*; D014168:Transferrin / Q000032:analysis
chemical_list: D006454:Hemoglobins; D014168:Transferrin; D007505:Iron-Dextran Complex; D007501:Iron